Marie-anne Goyette

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Breast cancer prevention by prophylactic Lalba mRNA-LNP vaccination.

Breast cancer prevention by prophylactic Lalba mRNA-LNP vaccination.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 02, 2026

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.

Journal: Cell reports

Published: August 01, 2026

HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies.

HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies.

Journal: Cancer discovery

Published: August 19, 2025

Whole-genome doubling drives immune evasion by silencing antigen presentation.

Whole-genome doubling drives immune evasion by silencing antigen presentation.

Journal: Cancer cell

Published: February 10, 2025

Inhibition of PAK2 in endothelial cells suppresses tumor angiogenesis and promotes immune sensitization through CXCL10.

Inhibition of PAK2 in endothelial cells suppresses tumor angiogenesis and promotes immune sensitization through CXCL10.

Journal: Cell reports

Published: August 26, 2024

Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies.

Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 06, 2024

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.

Journal: Cell reports

Published: December 15, 2023

HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial.

HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial.

Journal: The Journal of clinical investigation

Published: October 06, 2023

Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3.

Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3.

Journal: Nature cell biology

Published: August 15, 2023

Clinical and translational relevance of intratumor heterogeneity.

Clinical and translational relevance of intratumor heterogeneity.

Journal: Trends in cancer

Published: April 12, 2023

A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer.

A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer.

Journal: Nature communications

Published: October 05, 2022

CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis.

CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis.

Journal: Cell reports

Published: May 10, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026